77.16
price down icon2.28%   -1.80
after-market アフターアワーズ: 77.16
loading
前日終値:
$78.96
開ける:
$79.03
24時間の取引高:
1.01M
Relative Volume:
0.88
時価総額:
$3.27B
収益:
-
当期純損益:
$-63.78M
株価収益率:
-28.79
EPS:
-2.68
ネットキャッシュフロー:
$-53.91M
1週間 パフォーマンス:
+8.72%
1か月 パフォーマンス:
+56.19%
6か月 パフォーマンス:
+592.64%
1年 パフォーマンス:
+397.81%
1日の値動き範囲:
Value
$76.42
$79.97
1週間の範囲:
Value
$71.50
$80.13
52週間の値動き範囲:
Value
$7.575
$83.00

Celcuity Inc Stock (CELC) Company Profile

Name
名前
Celcuity Inc
Name
セクター
Healthcare (1135)
Name
電話
763-392-0767
Name
住所
16305 36TH AVENUE N, MINNEAPOLIS, MN
Name
職員
87
Name
Twitter
Name
次回の収益日
2025-03-31
Name
最新のSEC提出書
Name
CELC's Discussions on Twitter

CELC を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CELC
Celcuity Inc
77.16 3.35B 0 -63.78M -53.91M -2.68
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Celcuity Inc Stock (CELC) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-22 開始されました Guggenheim Buy
2025-07-01 再開されました Stifel Buy
2024-07-22 開始されました Leerink Partners Outperform
2024-02-22 開始されました Stifel Buy
2023-12-08 開始されました H.C. Wainwright Buy
2021-10-08 開始されました Canaccord Genuity Buy
2021-09-07 開始されました Jefferies Buy
2021-07-29 開始されました Cowen Outperform
2021-07-27 開始されました Needham Buy
2021-01-28 繰り返されました H.C. Wainwright Buy
2020-12-24 繰り返されました H.C. Wainwright Buy
2020-05-11 再開されました Craig Hallum Buy
2018-11-20 開始されました H.C. Wainwright Buy
すべてを表示

Celcuity Inc (CELC) 最新ニュース

pulisher
12:58 PM

Sector ETF performance correlation with Celcuity Inc.Gap Up & Safe Capital Allocation Plans - newser.com

12:58 PM
pulisher
04:30 AM

Will Celcuity Inc. stock benefit from AI adoptionQuarterly Earnings Summary & Fast Exit and Entry Strategy Plans - newser.com

04:30 AM
pulisher
Nov 01, 2025

Price action breakdown for Celcuity Inc.Weekly Trend Report & AI Based Trade Execution Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Why analysts upgrade Celcuity Inc. stockQuarterly Market Summary & Daily Oversold Stock Bounce Ideas - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

How to track smart money flows in Celcuity Inc.Analyst Downgrade & Daily Price Action Insights - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

What institutional flow reveals about Celcuity Inc.Market Sentiment Summary & Fast Moving Stock Trade Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Candlestick signals on Celcuity Inc. stock todayJuly 2025 Institutional & Expert Approved Trade Ideas - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How buybacks impact Celcuity Inc. stock valueTrade Signal Summary & Safe Entry Trade Signal Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Celcuity (CELC) Is Up 11.9% After Revealing Efficacy of Gedatolisib in ESMO Trial Results - simplywall.st

Oct 31, 2025
pulisher
Oct 30, 2025

Celcuity : Corporate Presentation (Celcuity Investor Presentation V.7.1.2 Final) - MarketScreener

Oct 30, 2025
pulisher
Oct 29, 2025

Celcuity (CELC) Price Target Increased by 10.74% to 84.15 - Nasdaq

Oct 29, 2025
pulisher
Oct 28, 2025

When is the best time to exit Celcuity Inc.Oil Prices & Reliable Entry Point Trade Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How currency fluctuations impact Celcuity Inc. stockEarnings Beat & Technical Buy Zone Confirmation - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

What analysts say about Celcuity Inc stockVolatility Trading Techniques & Grow Steadily With Our Wealth Roadmap - earlytimes.in

Oct 28, 2025
pulisher
Oct 27, 2025

Published on: 2025-10-27 20:00:39 - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is It Too Late to Buy Celcuity Stock? - StocksToTrade

Oct 27, 2025
pulisher
Oct 27, 2025

Celcuity Inc.’s Promising Phase 3 Breast Cancer Study: A Market Game-Changer? - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Celcuity’s Phase 3 Breast Cancer Study: A Potential Game-Changer? - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Celcuity Shares Surge Amid Promising Cancer Study - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Celcuity Inc.’s Promising Study on mCRPC Treatment: Key Insights for Investors - TipRanks

Oct 27, 2025

Celcuity Inc (CELC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
大文字化:     |  ボリューム (24 時間):